Ludwig-Maximilians-Universität München
Welcome,         Profile    Billing    Logout  
 1 Trial 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stephens, Andrew
CArdiag, NCT05184088: Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Recruiting
3
200
Europe, US
[18F]florbetaben, Neuraceq
Life Molecular Imaging GmbH, pharmtrace klinische Entwicklung GmbH
Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis
03/26
03/26
NCT05641688: [18F]PI-2620 Phase 3 Histopathological Study

Recruiting
3
200
US
[18F]PI-2620
Life Molecular Imaging Ltd
Alzheimer Disease
12/25
03/26
NCT04715750: Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Completed
1
10
Europe
[18F]-PI2620
Life Molecular Imaging GmbH, Life Molecular Imaging SA
Alzheimer Disease, Progressive Supranuclear Palsy
10/22
10/22
NCT05187546: Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

Completed
1
15
Europe
[18F]-PI2620
Life Molecular Imaging GmbH
Progressive Supranuclear Palsy
02/24
03/24
NCT05666167: Expanding Exercise Programming for Veterans Through Telehealth

Recruiting
N/A
50
US
Group Telehealth Exercise Sessions with text messaging plus booster sessions
VA Office of Research and Development
Arthritis
03/26
03/27
Theurich, Sebastian
AlloRelapseMM, NCT05675319: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Terminated
3
28
Europe
Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD), elotuzumab/lenalidomide/dexamethasone (ERD), daratumumab/bortezomib/dexamethasone (DVD), daratumumab/lenalidomide/dexamethasone (DRD), ixazomib/lenalidomide/dexamethasone (IRD), pomalidomide/bortezomib/dexamethasone (PVD), carfilzomib/daratumumab/dexamethasone (KDD), Autologous Stem Cells, daratumumab/pomalidomide/dexamethasone (DPD), isatuximab/carfilzomib/dexamethasone (Isa-KD), selinexor/bortezomib/dexamethasone (SVD)
Universitätsklinikum Hamburg-Eppendorf, Gemeinsamer Bundesausschuss (G-BA), Staburo GmbH
Multiple Myeloma
03/25
03/25
Brendel, Matthias
NCT05187546: Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

Completed
1
15
Europe
[18F]-PI2620
Life Molecular Imaging GmbH
Progressive Supranuclear Palsy
02/24
03/24
ICARUS, NCT04412187: Inflammatory faCtors AfteR acUte Ischemic Stroke

Recruiting
N/A
36
Europe
[18F]-GE-180 PET, TSPO PET imaging, 3T MRI, immune cell profiling in blood
Martin Dichgans, Universitätsklinikum Hamburg-Eppendorf, University Hospital Muenster
Ischemic Stroke
12/26
12/27
AmyClearAD, NCT05059158: Amyloid-β Clearance Mechanisms in Alzheimer's Disease

Recruiting
N/A
60
Europe
positron emission tomography (PET)
Ludwig-Maximilians - University of Munich
Alzheimer's Disease (AD)
09/25
10/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stephens, Andrew
CArdiag, NCT05184088: Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Recruiting
3
200
Europe, US
[18F]florbetaben, Neuraceq
Life Molecular Imaging GmbH, pharmtrace klinische Entwicklung GmbH
Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis
03/26
03/26
NCT05641688: [18F]PI-2620 Phase 3 Histopathological Study

Recruiting
3
200
US
[18F]PI-2620
Life Molecular Imaging Ltd
Alzheimer Disease
12/25
03/26
NCT04715750: Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Completed
1
10
Europe
[18F]-PI2620
Life Molecular Imaging GmbH, Life Molecular Imaging SA
Alzheimer Disease, Progressive Supranuclear Palsy
10/22
10/22
NCT05187546: Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

Completed
1
15
Europe
[18F]-PI2620
Life Molecular Imaging GmbH
Progressive Supranuclear Palsy
02/24
03/24
NCT05666167: Expanding Exercise Programming for Veterans Through Telehealth

Recruiting
N/A
50
US
Group Telehealth Exercise Sessions with text messaging plus booster sessions
VA Office of Research and Development
Arthritis
03/26
03/27
Theurich, Sebastian
AlloRelapseMM, NCT05675319: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Terminated
3
28
Europe
Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD), elotuzumab/lenalidomide/dexamethasone (ERD), daratumumab/bortezomib/dexamethasone (DVD), daratumumab/lenalidomide/dexamethasone (DRD), ixazomib/lenalidomide/dexamethasone (IRD), pomalidomide/bortezomib/dexamethasone (PVD), carfilzomib/daratumumab/dexamethasone (KDD), Autologous Stem Cells, daratumumab/pomalidomide/dexamethasone (DPD), isatuximab/carfilzomib/dexamethasone (Isa-KD), selinexor/bortezomib/dexamethasone (SVD)
Universitätsklinikum Hamburg-Eppendorf, Gemeinsamer Bundesausschuss (G-BA), Staburo GmbH
Multiple Myeloma
03/25
03/25
Brendel, Matthias
NCT05187546: Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

Completed
1
15
Europe
[18F]-PI2620
Life Molecular Imaging GmbH
Progressive Supranuclear Palsy
02/24
03/24
ICARUS, NCT04412187: Inflammatory faCtors AfteR acUte Ischemic Stroke

Recruiting
N/A
36
Europe
[18F]-GE-180 PET, TSPO PET imaging, 3T MRI, immune cell profiling in blood
Martin Dichgans, Universitätsklinikum Hamburg-Eppendorf, University Hospital Muenster
Ischemic Stroke
12/26
12/27
AmyClearAD, NCT05059158: Amyloid-β Clearance Mechanisms in Alzheimer's Disease

Recruiting
N/A
60
Europe
positron emission tomography (PET)
Ludwig-Maximilians - University of Munich
Alzheimer's Disease (AD)
09/25
10/25

Download Options